Other languages I-Mab Deutsche Boerse AG

Equities

0VY

US44975P1030

Real-time Estimate Tradegate Other stock markets 20:13:34 27/06/2024 BST			5-day change	1st Jan Change
1.565 ^EUR	-1.57%		-1.26%	-4.85%

06-06	I-Mab Appoints Phillip Dennis as Chief Medical Officer	CI
06-05	I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

I-Mab Appoints Phillip Dennis as Chief Medical Officer	06-06
I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers	06-05
I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers	06-05
I-Mab Announces Chief Medical Officer Changes	04-15
I-mab Biopharma Co., Ltd. completed the acquisition of I-Mab Biopharma Co., Ltd. from I-Mab.	04-01
I-Mab Announces Executive Resignation	04-01
I-Mab Reports Earnings Results for the Full Year Ended December 31, 2023	03-14
Gilead Sciences pauses enrollment for cancer treatment in solid tumor trials	02-15
Biotech firm I-Mab to divest China operations, shift focus to US	02-07
Biotech firm I-Mab to divest China operations	02-07
I-Mab Announces Board Changes , Effective February 10, 2024	02-07
Asian Equities Traded in the US as American Depositary Receipts Advance in Thursday Trading	01-11
I-Mab Says FDA Grants Breakthrough Therapy Designation for Felzartamab to Treat Kidney Disease	11-02
I-Mab and Hi-Bio Announces That the U.S. Food and Drug Administration Has Granted Breakthrough Therapy Designation for Felzartamab, an Investigational Cd38 Antibody, for the Treatment of Primary Memorbranous Nephropathy	11-02
I-Mab Announces Phase 1 Data of Givastomig at Esmo 2023	16/10/23
I-Mab and ABL Bio Announce Latest Updates of PD-L1 and 4-1Bb Bispecific Antibody Tj-L14b Abl503	10/10/23
I-Mab Regains Global Rights to Lemzoparlimab	22/09/23
Sector Update: Health Care Stocks Edge Higher Premarket Thursday	31/08/23
Sector Update: Health Care	31/08/23
Salesforce Earnings, Inflation Outlook Bolster Exchange-Traded Funds, Equity Futures Premarket Thursday	31/08/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages I-Mab Deutsche Boerse AG

Equities

0VY

US44975P1030

Other languages

Filters